Search

Stryker Corp

Abierto

SectorSanidad

337.76 -0.9

Resumen

Variación precio

24h

Actual

Mínimo

334.39

Máximo

341.74

Métricas clave

By Trading Economics

Ingresos

531M

1.3B

Ventas

569M

6.6B

P/B

Media del Sector

35.072

57.002

BPA

3.69

Rentabilidad por dividendo

1.03

Margen de beneficios

19.366

Empleados

56,000

EBITDA

266M

1.6B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+12.82% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

1.03%

2.22%

Próximas Ganancias

29 oct 2026

Fecha Próximo Dividendo

30 oct 2026

Próxima Fecha de Ex Dividendo

29 sept 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3.6B

133B

Apertura anterior

338.66

Cierre anterior

337.76

Noticias sobre sentimiento de mercado

By Acuity

61%

39%

296 / 340 Clasificación en Healthcare

Stryker Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ago 2026, 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12 ago 2026, 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11 ago 2026, 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10 ago 2026, 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7 ago 2026, 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

6 ago 2026, 20:06 UTC

Macro Event
News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

5 ago 2026, 23:12 UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

4 ago 2026, 19:56 UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

3 ago 2026, 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31 jul 2026, 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30 jul 2026, 23:41 UTC

Social Media
News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29 jul 2026, 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28 jul 2026, 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27 jul 2026, 19:06 UTC

Social Media
News
Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24 jul 2026, 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22 jul 2026, 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21 jul 2026, 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20 jul 2026, 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Comparación entre iguales

Cambio de precio

Stryker Corp previsión

Precio Objetivo

By TipRanks

12.82% repunte

Estimación a 12 Meses

Media 384.82 USD  12.82%

Máximo 455 USD

Mínimo 340 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stryker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

18 ratings

16

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

296 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat